Former Trump Drug Czar Says Top Federal Officials Stopped FDA From Scheduling Kratom Amid Concern About Agency’s ‘Bias’

As the U.S. Food and Drug Administration (FDA) under the Trump administration prepared to propose federal restrictions on kratom, a number of top officials intervened, criticizing the agency’s “bias” and stopping it “on the spot” from moving ahead with scheduling, a former White House drug czar said in a new interview.

“They did not give—did not have—the entire facts. They didn’t have the science,” said Jim Carroll, who served as director of the Office of National Drug Control Policy, or drug czar, under President Donald Trump from 2018 to 2021. “FDA did not paint the entire picture. Maybe they didn’t have the entire picture, but everyone else did.”

Carroll, who now works as a private lawyer and consultant, made the comments during a discussion with Mac Haddow, senior fellow at the American Kratom Association (AKA), during the National Conference of State Legislatures summit in Indianapolis earlier this month.

The former White House official said that as the Trump administration was considering whether to schedule kratom under the Controlled Substances Act, around 2018, FDA gave a presentation to his office that misstated the drug’s risk profile and potential benefits.

The agency was “talking about kratom being an opioid. We know that’s wrong, it’s flat-out wrong,” Carroll said. “They said that it’s highly addictive. Johns Hopkins [and] other medical, independent researchers have said it’s no more addictive than a cup of coffee in the morning, which I had before this interview.”

Keep reading

Innocent Man Beaten to Death in Jail After Being Sentenced to a Decade for Having Kratom

Last week, the Free Thought Project delved into the deeply unsettling story of Shaina Brown, an Alabama resident facing a potential life sentence over the mere possession of kratom. In our coverage, we touched upon the tragic case of Marshall Price, another victim of the merciless war on drugs. This week, we continue our exposé by shifting our focus to Price’s case, highlighting the gruesome realities of this ongoing war on a widely beneficial plant.

Before moving into the details of Marshall’s story, it is important to point out the massive disinformation campaign waged by the media and the government over this plant. A recent story out of Florida is gaining traction and serves as a perfect example of this propaganda after a judge awarded the family of Krystal Talavera $11 million in a lawsuit. Talavera, who had life-threatening pre-existing conditions, died after ingesting a substance in a baggy that had “Space Dust” written on it with a sharpy. This is “kratom,” according to the media, which is unwilling to do even 30 seconds of research to find out the truth.

The court ruled that Talavera died from kratom, and the media ran with it. But this was simply not the case. Talavera ingested a highly potent and concentrated alkaloid extract of the kratom plant, not kratom leaves. This is the equivalent of extracting lethal doses of caffeine from the coffee bean and calling it “coffee.”

Keep reading

Innocent Woman Facing Life in Prison for Legally Purchasing Kratom & Driving 200 Feet Into Alabama

In a disgusting display of what’s fundamentally wrong with America’s drug war, Shaina Brown, an entirely innocent woman, who harmed no one, finds herself locked up behind bars, slapped with an egregious $1,000,000 bail, later lowered to a still absurdly high $250,000, all for the mere possession of a plant she bought legally, just 200 feet away from where she was arrested. The plant in question? Kratom, a botanical supplement that has been vilified by a select few states and the federal government, despite it being perfectly legal in the majority of the US, including where Brown had initially bought it. It is also extremely safe when consumed properly.

To show just how insidious the state’s war on kratom actually is, we compared some of the recent bail amounts in Escambia County to Shaina’s case. Folks with crimes like strangulation, assault, battery, murder, and sexual abuse all have lower bonds than Shaina.

According to local law enforcement, the arrest happened in the dead of night on April 1, 2023, after Brown crossed over the unmarked state line from Florida, where Kratom is legal, into Alabama, where it is not. For those who may be unaware, kratom is ground-up tea leaves that are consumed by millions worldwide for its therapeutic benefits. Shaina’s mistake? Unknowingly bringing it into a state that has criminalized it.

Now, Brown faces the grim reality of the drug war in America. A plant purchased legally turns into a Schedule 1 substance the moment she crosses that imaginary line drawn on a map, transforming her, in the eyes of Alabama law, from a law-abiding citizen to a felon, with potential charges carrying a sentence of 10 years to life in prison.

The charges are shocking, especially considering Shaina’s history of minor offenses: a solitary speeding ticket and a cold check written in 2014 for under $500. A woman who isn’t a hardened criminal is now facing the prospect of losing years of her life, all for unknowingly “trafficking” tea powder in Alabama.

What’s most chilling about these proceedings is the manner in which they’re carried out. Juries are informed that the defendants are charged with possession or trafficking of a Schedule 1 substance, but they’re not told that this substance is Kratom. This omission paints an unfair picture, aligning defendants like Shaina with the likes of hardened criminals involved in the trade of far more dangerous and illicit substances like fentanyl.

Keep reading

American Medical Association Promotes Psychedelics Research, Opposes Kratom Criminalization And Affirms Support For Marijuana Drug Testing

The American Medical Association (AMA) has adopted a series of new drug policy positions, including advocating for psychedelics research, opposing the criminalization of kratom, calling for an end to the sentencing disparity between crack and powder cocaine and supporting the continued inclusion of marijuana metabolites in employment-based drug tests.

The organization’s House of Delegates, which met last month to consider numerous resolutions, also declined to approve an additional measure to revise its stance on marijuana in a way that would have maintained its opposition to legalization while implicitly recognizing the benefits of regulating cannabis products—instead opting to continuing its advocacy for prohibition without the newly proposed regulatory language.

This comes about a year after AMA delegates voted to amend its policy position to support the expungement of past marijuana convictions in states that have legalized the plant.

At the most recent meeting, the body tackled several different areas of drug policy.

The American Kratom Association (AKA) cheered the adoption of a new resolution that says people “who are using kratom only for personal use should not face criminal consequences”—though the measure also says that the substance should be “evaluated by the relevant regulatory entities for its appropriateness for sale and potential oversight via the Controlled Substances Act, before it can be marketed, purchased, or prescribed.”

Keep reading